Compare PCSA & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCSA | CTNT |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 3.5M |
| IPO Year | 2012 | 2023 |
| Metric | PCSA | CTNT |
|---|---|---|
| Price | $1.69 | $2.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 172.4K | ★ 32.3M |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.74 |
| EPS | N/A | ★ N/A |
| Revenue | $5,000.00 | ★ $1,288,536.00 |
| Revenue This Year | N/A | $78.50 |
| Revenue Next Year | N/A | $52.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 182.69 |
| 52 Week Low | $0.11 | $0.03 |
| 52 Week High | $8.88 | $2,120.00 |
| Indicator | PCSA | CTNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 53.31 |
| Support Level | $1.04 | $0.04 |
| Resistance Level | $2.33 | $4.18 |
| Average True Range (ATR) | 0.22 | 0.37 |
| MACD | 0.03 | 0.15 |
| Stochastic Oscillator | 65.92 | 19.25 |
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.